Sandra Knowles
ARTICLES BY THIS AUTHOR
- 9/19/2022
Stroke risk with antidopaminergic antiemetics
Antipsychotic medications with centrallyacting antidopaminergic properties (e.g., risperidone, haloperidol) have been shown to increase the risk of ischemic stroke, especially in older patients and patients with dementia. - 9/19/2022
Tofacitinib: cardiovascular and cancer risks
Janus kinase inhibitors are oral targeted agents used for the treatment of various chronic inflammatory diseases including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and atopic dermatitis. - 5/24/2022
Is apixaban preferred over rivaroxaban in AF?
For patients with a higher baseline bleeding risk, apixaban may be a better choice than rivaroxaban. - 5/24/2022
Myocarditis/pericarditis risk with COVID-19 vaccines
Cases of myocarditis/ pericarditis following COVID-19 vaccination have generally occurred more frequently in adolescents and young men (<30 years). - 10/7/2021
Safety and Efficacy of DOACS in CKD/Dialysis
Data are limited on the safety and efficacy of DOACs in patients with CKD - 8/12/2021
Practice Experts: CNS-active drug polypharmacy in patients with dementia
Although psychotropic medications are often prescribed in community-dwelling persons with dementia, there is limited evidence for the use of these medications in this population - 11/12/2020
Adverse Reactions: ACEIs, ARBs and COVID-19
- 5/5/2020
Mortality in patients prescribed hypnotics/anxiolytics
Mortality of multimorbid patients who did not use the drugs was approximately 14% higher than in patients who were neither multimorbid nor using the drugs
